1) Anomalous Expression of Thy1 (CD90) in B-Cell Lymphoma Cells and Proliferation Inhibition by Anti-Thy1 Antibody
丂Treatment.
丂Ishiura Y, Kotani N, Yamashita R, Yamamoto H, Kozutsumi Y, Honke K.
丂Biochem. Biophys. Res. Commun.2010; 396: 329-334 (IF: 2.548)

2) Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by upregulation of
丂transcription of the CYP11B2 gene.
丂Yamashiro T, Kuge H, Honke K.
丂J. Biochem. 2010; 148: 115-123 (IF: 1.945)

3) HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the
丂mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
丂Nakabayashi H, Shimizu K.
丂Cancer Sci. 2010 Nov 10. doi

4) A cystic meningioma misdiagnosed as malignant glioma by radiologic and intraoperative histological examinations.
丂Yamada SM, Fujimoto Y, Kawanishi Y, Shimizu K.
丂Brain Tumor Pathol. 2010; 27: 111-115 (IF: 1.100)

5) Effects of edible algae polysaccharides on allergic, inflammatory, and anti-tumorresponses through toll-like receptor
丂4.
丂Tominaga A, Okuyama H, Fukuoka S, Taguchi T, Kusumoto Y, Shimizu K, Ono S.
丂Anti-Inflammatory & Abti-Allergy Agents in Medical Chemistry 2010; 9: 238-250

6) Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
丂Nakabayashi H, Yawata T, Shimizu K.
丂BMC Cancer. 2010; 10: 339 (IF: 2.736)

7) Enhanced expression of cancer testis antigen genes in glioma stem cells.
丂Yawata T, Nakai E, Park KC, Chihara T, Kumazawa A, Toyonaga S, Masahira T, Nakabayashi H, Kaji T, Shimizu K.
丂Mol Carcinog. 2010; 49: 532-544 (IF: 3.202)

8) Preoperative surgical approach planning for metastatic pituitary stalk tumor using multimodal fusion imaging in a
丂neuronavigation system--case report.
丂Yamada SM, Masahira N, Ikawa N, Nakai E, Park KC, Shimizu K.
丂Neurol Med Chir (Tokyo). 2010; 50: 259-263 (IF: 0.733)

9) Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic
丂potential.
丂Hoshiba H, Uchiyama J, Kato S, Ujihara T, Muraoka A, Daibata M, Wakiguchi H, Matsuzaki S.
丂Arch Virol. 2010; 155: 545-552 (IF: 1.909)

10) Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with
丂spondyloarthritides.
丂Taniguchi Y, Arii K, Kumon Y, Fukumoto M, Ohnishi T, Horino T, Kagawa T, Kobayashi S, Ogawa Y, Terada Y
丂Rheumotology (Oxford) 2010; 49: 348-354

11) Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver
丂disease.
丂Asanuma T, Ono M, Kubota K, Hirose A, Hayashi Y, Saibara T, Inanami O, Ogawa Y, Enzan H, Onishi S, Kuwabara M,
丂Oben JA
丂Gut 2010; 59: 258-266

12) A totally implanted intra-arterial chemotherapy system for advanced maxillary sinus carcinoma.
丂Nakatani H, Hirose K, Matsumoto N, Yamagawa K, Kakigi A, Takeda T, Ito S, Yamanishi T, Nishioka A, Ogawa Y,
丂Nakahira M.
丂ORL J Otorhinolaryngeal Relat Spec 2010; 71 (Suppl 1): 116-122

13) Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization
丂for hepatocellular carcinoma.
丂Kubota K, Yamanishi T, Itoh S, Murata Y, Miyatake K, Yasunami H, Morio K, Hamada N, Nishioka A, Ogawa Y.
丂Oncol Rep 2010; 24: 727-732

14) Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-
丂targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).
丂Hitomi J, Kubota K, Ogawa Y, Hamada N, Murata Y, Nishioka A
丂Exp Ther Med 2010; 1: 769-775

15) Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new enzyme
丂-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II
丂(KORTUC II) with systemic chemotherapy.
丂Miyatake K, Kubota K, Ogawa Y, Hamada N, Murata Y, Nishioka A.
丂Oncol Rep 2010; 24: 1161-1168

16) Development of a new enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral
丂injection for patients with low linear energy transfer (LET)-radioresistant neoplasms.
丂Tokuhiro S, Ogawa Y, Tsuzuki K, Akima R, Ue H, Kariya S, Nishioka A.
丂Oncol Letters 2010; 1: 1025-1028

挊彂

1) 彫愳嫳峅
丂曻幩慄偺憡屳嶌梡丄偑傫丒曻幩慄椕朄丄pp182-190丄幝尨弌斉怴幮丄搶嫗丄2010

丂 戞4475469崋丂乽俫俴俙寢崌惈儁僾僠僪丄偦傟傪僐乕僪偡傞俢俶俙抐曅偍傛傃慻傒姺偊儀僋僞乕乿
丂 敪柧幰丗媨愳抦栫丄塅崅宐巕丂丂暯惉22擭3寧19擔

弌婅

1) 摿婅2010-157181, 嵶朎枌忋暘巕偲憡屳嶌梡偡傞壔崌暔偺専弌曽朄
丂 杮壠岶堦丄彫扟揟峅丄暯惉22擭7寧9擔

2) PCT/JP2010/055696, Tumor-specific promoter and use thereof
丂 Shimizu K丄 Yawata T丄 2010/03/30

曬摴

徏嶈栁揥
丂妞嫣怴暦梉姧丂丂2010擭11寧25擔乮栘梛乯
丂壢妛丗峈嬠丂暿偺嶌愴偼丠

1) Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves
丂insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas.
丂Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Namikawa T, Maeda H, Yatabe T, Hanazaki K.
丂Amino Acids. 2010; 38: 901-907 (IF: 3.877)

2) Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration.
丂Maeda H, Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Hanazaki K.
丂Am J Surg. 2010; 199: 8-13 (IF: 2.363)

3) Tight perioperative glycemic control using an artificial endocrine pancreas.
丂Hanazaki K, Maeda H, Okabayashi T.
丂Surg Today. 2010; 40: 1-7 (IF: 1.050)

4) Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative
丂quality of life in patients undergoing hepatic resection.
丂Okabayashi T, Iyoki M, Sugimoto T, Kobayashi M, Hanazaki K.
丂Amino Acids. 2010 Sep 18. [Epub ahead of print] PMID: 20852905 (IF: 3.877)

5) Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated
丂immobilization stress.
丂Noguchi T, Makino S, Matsumoto R, Nakayama S, Nishiyama M, Terada Y, Hashimoto K.
丂Endocrinology. 2010; 151: 4344-4355 (IF: 4.752)

6) Serum fetuin-A is an independent marker of insulin resistance in Japanese men.
丂Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, Inoue M, Suehiro T, Terada Y.
丂J Atheroscler Thromb. 2010; 17: 925-933 (IF: 3.048)

7) Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene
丂induction.
丂Taniguchi Y, Iwasaki Y, Tsugita M, Nishiyama M, Taguchi T, Okazaki M, Nakayama S, Kambayashi M, Hashimoto K,
丂Terada Y.
丂Endocrinology. 2010; 151: 3204-3213 (IF: 4.752)

8) Coincidental double erythema caused by Vibrio vulnificus.
丂Taguchi T, Mizobuchi M, Terada Y.
丂J Infect. 2010; 61: 95-96 (IF: 3.060)

9) Rapid recurrence of craniopharyngioma following recombinant human growth hormone replacement.
丂Taguchi T, Takao T, Iwasaki Y, Pooh K, Okazaki M, Hashimoto K, Terada Y.
丂J Neurooncol. 2010; 100: 321-322 (IF: 2.752)

10) Hypoglycemic encephalopathy as a result of an attempted suicide.
丂Taguchi T, Mizobuchi M, Terada Y.
丂Clin Neurol Neurosurg. 2010; 112: 455-456 (IF: 1.303)

11) PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1.
丂Okazaki M, Iwasaki Y, Nishiyama M, Taguchi T, Tsugita M, Nakayama S, Kambayashi M, Hashimoto K, Terada Y.
丂Endocr J. 2010; 57:403-413 (IF: 1.806)

12) Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.
丂Zhao LF, Iwasaki Y, Zhe W, Nishiyama M, Taguchi T, Tsugita M, Kambayashi M, Hashimoto K, Terada Y.
丂Endocr J. 2010; 57:317-324 (IF: 1.806)

13) The activity of carotidynia syndrome is correlated with the soluble intracellular adhesion molecule-1 (sICAM-1)
丂level.
丂Taniguchi Y, Horino T, Terada Y, Jinnouchi Y.
丂South Med J. 2010; 103: 277-278 (IF: 0.924)

14) IgA nephropathy in a patient with systemic lupus erythematosus.
丂Horino T, Takao T, Terada Y.
丂Lupus. 2010; 19: 650-654 (IF: 2.586)

15) Clinical implication of 18F-fluorodeoxyglucose PET/CT in monitoring disease activity in spondyloarthritis.
丂Taniguchi Y, Kumon Y, Arii K, Tsugita M, Fukumoto M, Ohnishi T, Kobayashi S, Terada Y.
丂Rheumatology (Oxford). 2010; 49: 829. (IF: 4.236)

16) Acute pulmonary arterial hypertension associated with anti-synthetase syndrome.
丂Taniguchi Y, Horino T, Kato T, Terada Y.
丂Scand J Rheumatol. 2010; 39: 179-180 (IF: 2.507)

17) Role of protein kinase C in pitavastatin-induced human paraoxonase I expression in Huh7 cells.
丂Arii K, Suehiro T, Ikeda Y, Kumon Y, Inoue M, Inada S, Takata H, Ishibashi A, Hashimoto K, Terada Y.
丂Metabolism. 2010; 59:1287-1293. (IF: 2.588)

18) A case of post-streptococcal reactive arthritis in which lesions were detected with [18F]-fluorodeoxyglucose
丂positron emission tomography-CT imaging and magnetic resonance imaging.
丂Horino T, Takao T, Terada Y.
丂Mod Rheumatol. 2010; 20: 287-290.

19) Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo.
丂Inoue K, Kuwana H, Shimamura Y, Ogata K, Taniguchi Y, Kagawa T, Horino T, Takao T, Morita T, Sasaki S,
丂Mizushima N, Terada Y.
丂Clin Exp Nephrol. 2010; 14: 112-122.

20) Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with
丂spondyloarthritides.
丂Taniguchi Y, Arii K, Kumon Y, Fukumoto M, Ohnishi T, Horino T, Kagawa T, Kobayashi S, Ogawa Y, Terada Y.
丂Rheumatology (Oxford). 2010; 49: 348-354. (IF: 4.236)

21) HLA-B51-related seronegative spondyloarthropathy associated with membranous nephropathy.
丂Horino T, Nakayama S, Takao T, Terada Y.
丂Rheumatology (Oxford). 2010; 49:394-396. (IF: 4.236)

22) Diagnostic value of 18F-dihydroxyphenylalanine positron emission tomography for growth hormone-producing
丂pituitary adenoma.
丂Taguchi T, Takao T, Iwasaki Y, Oyama K, Yamada S, Inoue M, Terada Y.
丂Pituitary. 2010 ;13: 78-79. (IF: 2.021)

1) 崄愳嫓丄帥揷揟惗
丂堦斒偺媫惈恡晄慡丒尨場偲娪暿恌抐偺恑傔曽
丂媫惈恡晄慡丒AKI僴儞僪僽僢僋丄p9-14 旽揷柧. 拞奜堛妛幮2010

2) 堜忋峢曘丄弿曽岻擇丄搰懞朏巕丄帥揷揟惗
丂栻暔偵傛傞CKD丏
丂恡偲摟愅vol69憹姧崋 乽AKI偲CKD偺偡傋偰乿丗p201-203丆搶嫗堛妛幮2010丏

3) 帥揷揟惗丄搰懞朏巕丄弿曽岻擇丄堜忋峢曘
丂AKI帯椕偵偍偗傞Stem cell偺壜擻惈
丂恡偲摟愅 68姫俁崋P381-384, 2010.

4) 帥揷揟惗
丂嘦.昦懺偲娪暿恌抐, 摿廤丂媫惈恡晄慡丗恌抐偲帯椕偺恑曕
丂擔杮撪壢妛夛嶨帍 99姫俆崋p924-929, 2010.

5) 堜忋峢曘丄帥揷揟惗
丂媫惈恡晄慡偲枬惈恡晄慡偺娪暿
丂憤崌椪彴59姫6崋p1350-1353, 2010.

6) 帥揷揟惗丄忋揷孭巕丄搰懞朏巕丄弿曽岻擇丄堜忋峢曘
丂擜嵶娗忈奞偲夞暅偺儊僇僯僘儉丄摿廤丗AKI丒媫惈恡晄慡
丂擔杮恡憻妛夛嶨帍丂52姫5崋p558-561, 2010.

7) 崄愳嫓丄帥揷揟惗
丂堦斒偺媫惈恡晄慡丄A.尨場偲娪暿恌抐偺恑傔曽
丂Modern Physician, P9-14, 2010.

8) 帥揷揟惗
丂OPINION丂恡憻昦尋媶偱偺嵞惗堛妛偺柌
丂椪彴摟愅丂26姫10崋p1285, 2010.

1) A classification algorithm of abdominal ultrasound images in medical practice for secondary uses.
丂Hatakeyama Y, Kataoka H, Nakajima N, Watabe T, Okuhara Y.
丂J Adv Comput Intel Intel Inform. 2010; 14: 128-124

2) Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.
丂Asanuma T, Ono M, Kubota K, Hirose A, Hayashi Y, Saibara T, Inanami O, Ogawa Y, Enzan H, Onishi S, Kuwabara M,
丂Oben JA.
丂Gut. 2010; 59: 258-266 (IF: 9.357)

3) Matrix metalloproteinase-1 expression in splenic angiosarcoma metastasizing to the serous membrane.
丂Takeuchi T, Iwasaki S, Miyazaki J, Nozaki Y, Takahashi M, Ono M, Saibara T, Furihata M.
丂Int J Clin Exp Pathol. 2010; 3: 634-639

4) Effects of Eriobotrya japonica seed extract on oxidative stress in rats with non-alcoholic steatohepatitis.
丂Yoshioka S, Hamada A, Jobu K, Yokota J, Onogawa M, Kyotani S, Miyamura M, Saibara T, Onishi S, Nishioka Y.
丂J Pharm Pharmacol. 2010; 62: 241-246 (IF: 1.742)

5) Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in
丂aromatase knockout mice.
丂Toda K, Hayashi Y, Saibara T.
丂Biochim Biophys Acta. 2010; 1801: 655-64. (IF: 2.958)

6) Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
丂Hidaka M, Iwasaki S, Matsui T, Kawakita T, Inoue Y, Sakai T, Harada N, Takemoto S, Nagakura S, Kiyokawa T,
丂Takahashi M, Saibara T, Onishi S, Kawano F.
丂Bone Marrow Transplant. 2010; 45: 912-918 (IF: 2.998)

1) 惣尨棙帯丄彫栰惓暥
丂昦婥偲栻僷乕僼僃僋僩BOOK (墶揷愮捗巕丄抮揷塅堦丄戝墇嫵晇 曇) NASH, 464-465暸, 撿嶳摪, 搶嫗, 2010

2) 彫妢尨岝惉丄淎悾丂嫕丄栰嶈丂桋巕丄崅嫶徆栫丄壀杮愰恖丄廐郪捈柧丄彫栰惓暥丄惣尨棙帯
丂巁壔僗僩儗僗偲娞幘姵乮壂揷嬌曇乯旕傾儖僐乕儖惈帀朾惈娞幘姵偵偍偗傞寣惔擜巁抣丄91-94暸丄儊僨傿僇儖僩儕價儏乕儞丄搶嫗
丂2010

3) 妏揷孿梇丄暷揷惓恖丄暫屔廏岾丄嶳岥姲擇丄彫栰惓暥丄摗堜塸庽丄峕岥桳堦�秮A楅栘峃廐丄嬥惌榓擵丄摗揷峗巌丄拑嶳堦塭丄
丂埨嫃岾堦榊丄惣尨棙帯丄壨揷懃暥丄摗杮堦崃丄崅屻桾丄壀忋晲
丂巁壔僗僩儗僗偲娞幘姵乮壂揷嬌曇乯NASH娪暿偺偨傔偺scoring system (NAFIC score)偺懡巤愝嫟摨(Japan Study Group of
丂NAFLD: JSG-NAFLD)偵傛傞validation study 丄95-100暸丄儊僨傿僇儖僩儕價儏乕儞丄搶嫗丄2010

4) 廐郪捈柧丄壀杮愰恖丄惣尨棙帯
丂娞幘姵review 乮彫枔惌抝娔廋乯NASH偵懳偡傞栻暔帯椕偺尰嫷偲揥朷丄82-87暸丄擔杮儊僨傿僇儖僙儞僞乕丄搶嫗丄2010

5) 惣尨棙帯
丂NASH丒NAFLD偺恌椕僈僀僪 (擔杮娞憻妛夛曇) NAFLD偺塽妛, 8-13暸,丂暥岝摪, 搶嫗, 2010

6) 娾嶈怣擇丄栰嶈桋巕丄惣尨棙帯
丂峀斖埻寣塼�擜壔妛専嵏丂峈暯妸嬝峈懱(ASMA), 596-598暸, 擔杮椪彴幮, 搶嫗, 2010

惣尨棙帯
丂1) 帀朾娞偑娞偑傫偵恑峴丂嶻宱怴暦丂2010.1.13
丂2) 娞娻偼梊杊偱偒傞偐丂撉攧怴暦2010擭俉寧俀俀擔
丂3) 昦堾偺幚椡丂崅抦曇丂乽娞憻偑傫乿丂撉攧怴暦2010擭11寧7擔

1) Association between brachial-ankle pulse wave velocity and 3-year mortality in community-dwelling older adults.
丂Miyano I, Nishinaga M, Takata J, Shimizu Y, Okumiya K, Matsubayashi K, Ozawa T, Sugiura T, Yasuda N, Doi Y.
丂Hypertens Res. 2010; 33: 678-682 (IF: 2.426)

2) Prevalence of Parkinson's disease and atypical parkinsonian syndromes in a rural Japanese district.
丂Osaki Y, Morita Y, Kuwahara T, Miyano I, Doi Y.
丂Acta Neurol Scand. 2010 Sep 29. doi: 10.1111/j.1600-0404.2010.01442.x. [Epub ahead of print]PMID: 20880268
丂(IF: 2.324)

3) Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer:
丂comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
丂Kitajima K, Murakami K, Yamasaki E, Kaji Y, Shimoda M, Kubota K, Suganuma N, Sugimura K.
丂Mol Imaging Biol. 2010; 12: 452-459 (IF: 2.467)

4) Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced
丂MRI in combination with T2-weighted imaging.
丂Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.
丂J Magn Reson Imaging. 2010; 31: 625-631 (IF: 2.770)

5) Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils.
丂Hirota R, Roger NN, Nakamura H, Song HS, Sawamura M, Suganuma N.
丂J Food Sci. 2010; 75: H87-92 (IF: 1.601)

6) Effect of a two-hour training on physicians' skill in interpreting Pneumoconiotic chest radiographs.
丂Ngatu NR, Suzuki S, Kusaka Y, Shida H, Akira M, Suganuma N.
丂J Occup Health. 2010; 52: 294-301 (IF: 1.252)

1) PCT/JP2010/061600, PROCESS FOR PREPARATION OF APHANOTHECE SACRUM-ORIGINATED POLYSACCHARIDE
丂WITH REDUCED TRIVALENT METAL CONTENT
丂KANEKO, Tatsuo; KANEKO, Maiko; NAKAMURA, Hiroyuki; KANEKO, Shinichiro; SUGANUMA, Narufumi; HIROTA, Ryoji;
丂08.07.2010

1) 愇尨惓峴丄埨摗愮宐丄愒搩桳棦崄丄崅悪彯巙丄摗巬姴栫丄榚岥岹
丂僱僷乕儖柉庡嫟榓崙丂AMDA巕偳傕昦堾朘栤嘆丏拞崙巐崙彫帣曐寬妛夛丄2010擭10寧丄峀搰

2) 悰徖惉暥
丂巕偳傕偺寬峃偲娐嫬偵娭偡傞慡崙挷嵏丄擔杮彫帣壢妛夛崅抦抧曽夛憤夛丄2010擭2寧14擔丄崅抦

3) 悰徖惉暥丄惎栰奊棦
丂巕偳傕偺寬峃偲娐嫬偵娭偡傞慡崙挷嵏丗彫帣壢堛偺娭傢傝丄擔杮彫帣壢妛夛崅抦抧曽夛憤夛丄2010擭9寧12擔丄崅抦

4) 塰摽彑岝丄悰徖惉暥
丂乽偙偆偪僄僐僠儖挷嵏乿偺幚巤偵岦偗偰丄戞60夞擔杮嶻壢晈恖壢妛夛崅抦抧曽晹夛妛弍廤夛丄2010擭12寧18擔丄崅抦

戞 7 夞擔杮妀堛妛夛尋媶彠椼徿庴徿
杒搰堦岹丄懞忋峃擇丄嶳嶈塸楁撧丄昐栚栘懽丄捴徆桾丄嵒愳惓彑丄灥桋丄悰徖惉暥丄悪懞榓楴
FDG-憿塭 PET/CT 偵傛傞戝挵娻弍屻偺嵞敪丒揮堏恌抐擻丗FDG-旕憿塭 PET/CT偍傛傃憿塭 CT 偲偺斾妑
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer:Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT (European Journal of Nuclear Medicine and Molecular Imaging 2009; 36(9):1388-1396 Germany)

悰徖惉暥

丂丂1) KSS偝傫偝傫崅抦乽SUNSUN僗乕僷乕僯儏乕僗乿乮暯惉22擭9寧6擔曻憲乯
丂丂2) KUTV僥儗價崅抦乽僀僽僯儞僌KOCHI乿乮暯惉22擭9寧6擔曻憲乯
丂丂3) RKC崅抦曻憲乽偙偆偪倕倷倕乿乮暯惉22擭9寧6擔曻憲乯
丂丂4) NHK憤崌乽偙偆偪忣曬偄偪偽傫乿乮暯惉22擭9寧6擔曻憲乯
丂丂5) NHK憤崌乽僯儏乕僗俉係俆偙偆偪乿乮暯惉22擭9寧6擔曻憲乯
丂丂6) 崅抦怴暦乮暯惉22擭9寧7擔宖嵹乯
丂丂7) 撉攧怴暦乮暯惉22擭9寧7擔宖嵹乯
丂丂8) 枅擔怴暦乮暯惉22擭9寧7擔宖嵹乯
丂丂9) 崅抦怴暦乮暯惉22擭9寧23擔宖嵹乯
丂 10) 撉攧怴暦乮暯惉22擭9寧24擔宖嵹乯
丂 11) 挬擔怴暦乮暯惉22擭10寧19擔宖嵹乯
丂 12) 枅擔怴暦乮暯惉22擭10寧20擔宖嵹乯
丂 13) 崅抦怴暦乮暯惉22擭11寧16擔宖嵹乯

偦偺懠偺妶摦
丂丂2010擭2寧12擔乣27擔丂僱僷乕儖AMDA昦堾朘栤乮庡偵尒妛乯
丂丂2011擭1寧27擔乣2寧10擔丂僱僷乕儖AMDA昦堾朘栤乮怴惗帣丒擕帣慼惗朄島廗側偳幚巤乯

1) New device for intraoperative graft assessment: HyperEye charge-coupled device camera system.
丂Handa T, Katare RG, Nishimori H, Wariishi S, Fukutomi T, Yamamoto M, Sasaguri S, Sato T.
丂Gen Thorac Cardiovasc Surg. 2010; 58: 68-77

2) Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.
丂Katare RG, Ando M, Kakinuma Y, Sato T.
丂PLoS One. 2010; 5: e9275 (IF: 4.351)

3) Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic
丂hindlimb model.
丂Kakinuma Y, Furihata M, Akiyama T, Arikawa M, Handa T, Katare RG, Sato T.
丂J Mol Cell Cardiol. 2010; 48: 680-693 (IF: 4.965)

4) Differential regulation of TNF receptors by vagal nerve stimulation protects heart against acute ischemic injury.
丂Katare RG, Ando M, Kakinuma Y, Arikawa M, Yamasaki F, Sato T.
丂J Mol Cell Cardiol. 2010; 49: 234-244 (IF: 4.965)

5) The effect of donepezil treatment on cardiovascular mortality.
丂Sato K, Urbano R, Yu C, Yamasaki F, Sato T, Jordan J, Robertson D, Diedrich A.
丂Clin Pharmacol Ther. 2010; 88: 335-338 (IF: 6.961)

6) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels.
丂Furuno T, Yamasaki F, Yokoyama T, Sato K, Sato T, Doi Y, Sugiura T.
丂Heart Vessels. 2010 Nov 10. [Epub ahead of print] (IF: 1.716)

丂 戞4544917崋 乽惗懱埑敆憰抲媦傃寣埑應掕憰抲乿
丂 敪柧幰:彫柛晀旻丄嵅摗棽岾丄嶳嶈暥桋丂 庢摼擔:2010.7.9

弌婅

1) 摿婅2010-123928乽LED徠幩憰抲乿
丂 敪柧幰:嵅摗丂宧丄彫媨宧揘丄嵅摗棽岾丂 弌婅擔:2010.5.31.

2) 摿婅2010-169802乽儂儚僀僩僶儔儞僗挷惢曽朄偍傛傃嶣憸憰抲乿
丂 敪柧幰:彫搱悢柧丄扟杮岶巌丄嵅摗棽岾丂 弌婅擔:2010.7.28.

3) 摿婅2010-268934乽嬤愒奜寀岝傪敪偡傞堛椕嬶媦傃堛椕嬶埵抲妋擣僔僗僥儉乿
丂 敪柧幰:嵅摗棽岾丄栰岥彑屓丂弌婅擔:2010.12.2.

曬摴

嵅摗棽岾
丂嘥.僥儗價曻憲

丂丂1)乽庤弍姵晹 僇儔乕塮憸偱妋擣乿俶俫俲憤崌曻憲乮崅抦乯乽偙偆偪忣曬偄偪偽傫乿2010.6.7
丂丂2)乽岝傞姵晹偱庤弍傪曄偊傞乿俶俫俲憤崌曻憲乮崅抦乯乽偍偼傛偆偙偆偪乿2010.7.6
丂丂3)乽岝傞姵晹偑堛椕傪曄偊傞乿俶俫俲憤崌曻憲乽僯儏乕僗僂僆僢僠俋乿2010.8.6
丂丂4)乽懱撪偺庤弍偺億僀儞僩傪壜帇壔. 嵟怴庤弍僫價僎乕僔儑儞僔僗僥儉姰惉乿 JST Science News 2010.9.
丂丂5)乽抧堟敪 偑傫帯椕妚柦乣堛椕奿嵎傪夝徚偣傛乣乿俶俫俲憤崌曻憲乮巐崙乯乽巐崙梾恓斦乿2010.10.29.

丂嘦.儔僕僆曻憲
丂丂1)乽悽奅弶偺夋婜揑側庤弍僫價僎乕僔儑儞僔僗僥儉偺奐敪乿嵅摗棽岾, 悪杮寬庽. FM儔僕僆曻憲婇夋
丂丂丂乽Change The 崅抦戝妛乿丂2010.6.26.

丂嘨.怴暦宖嵹
丂丂1)乽擔杮敪偺夋婜揑側僨僶僀僗偑懕乆偲搊応, 僇儔乕俬俠俧寀岝嶣塭憰抲偼僫價僎乕僔儑儞庤弍偵桳梡乿 Medical Tribune
丂丂丂丂2010.5.20.
丂丂2)乽庤弍帪丄栚揑晹埵偑敪岝丂崅抦戝側偳丄愒奜慄僇儊儔奐敪乿 擔杮宱嵪怴暦 2010.6.5.
丂丂3) 儕儞僷愡傗寣娗丄庤弍拞偔偭偒傝丂崅抦戝丄寀岝僫價奐敪乿挬擔怴暦乮戝嶃乯 2010.6.5.
丂丂4)乽崅抦戝堛妛晹丂嬤愒奜慄偱儕儞僷娗乬摟帇乭悽奅弶 庤弍梡僫價惢昳壔乿 崅抦怴暦2010.6.5.
丂丂5)乽崅抦戝偑寀岝僇儊儔奐敪亅奜壢愗彍晹傪壜帇壔乿 擔姧岺嬈怴暦 2010.6.5.
丂丂6)乽崅抦戝丄庤弍僔僗僥儉傪惢昳偵丂姵晹傪嬤愒奜摟夁偱壜帇壔乿 FujiSankei Business 2010.6.11.
丂丂7)乽庤弍梡僇儊儔丗寣棳偔偭偒傝丂悽奅弶丄崅抦戝堛妛晹丒嵅摗嫵庼僠乕儉偑惢昳壔乿 枅擔怴暦乮崅抦乯 2010.06.15.
丂丂8)乽悙曚堛壢側偳丄嬤愒奜岝棙梡怴僔僗僥儉丄弍拞偵旝嵶愗彍慻怐傪壜帇壔乿 壔妛岺嬈擔曬 2010.6.16.
丂丂9)乽奜壢庤弍偺愗彍晹暘傪儕傾儖僞僀儉偱壜帇壔乿 壢妛怴暦 2010.6.18.
丂 10)乽儕儞僷愡傗寣娗偺忬懺丄庤弍帪丄僇儔乕偱娤嶡丄崅抦戝側偳丄嬤愒奜寀岝傪嶣塭乿 擔宱嶻嬈怴暦 2010.6.23.
丂 11)乽擣抦徢栻丂怱憻昦梊杊偵岠壥崅抦戝側偳乿擔杮宱嵪怴暦 2010.12.5.
丂 12)乽擣抦徢栻丂怱憻昦偵岠壥丂崅抦戝偲暷崌摨僠乕儉丂怱嬝嵶朎嵞惗懀偡乿崅抦怴暦 2010.12.5.

岞奐島墘

嵅摗棽岾
丂1) 悽奅弶両恎懱揑�惛恄揑偵晧扴偺彮側偄奜壢庤弍偺幚尰傊
丂丂乣嬤愒奜寀岝傪曔懆偡傞弍拞僫價僎乕僔儑儞僇儔乕僀儊乕僕儞僌僔僗僥儉偺奐敪乣
丂 乽乬抦乭偲乬抧乭偺嫤憈丂抧堟峷專傪栚巜偡崅抦敪偺壢妛媄弍乣JST僀僲儀乕僔儑儞僒僥儔僀僩崅抦丂尋媶惉壥曬崘夛乣乿
丂丂2010.9.9. 怴嶃媫儂僥儖丄崅抦巗

1) Effects of Eriobotrya japonica seed extract on oxidative stress in rats with non-alcoholic steatohepatitis.
丂Yoshioka S, Hamada A, Jobu K, Yokota J, Onogawa M, Kyotani S, Miyamura M, Saibara T, Onishi S, Nishioka Y.
丂J Pharm Pharmacol. 2010; 62:241-246 (IF: 1.742)

2) Protective effects of Flos lonicera extract on acute liver injury by dimethylnitrosamine-induced in rats.
丂Teng Y, Sun C, Li G, Sun G, Nomachi Y, Yokota J, Yoshioka S, Gang J, Jiao S, Zhang Y, Miyamura M.
丂J Nat Med. 2010; 64: 288-294 (IF: 1.027)

3) Immunomodulatory effect of Eriobotrya japonica seed extract on allergic dermatitis rats.
丂Sun G, Liu Y, Zhu J, Iguchi M, Yoshioka S, Miyamura M, Kyotani S.
丂J Nutr Sci Vitaminol (Tokyo). 2010; 56: 145-149 (IF: 0.929)

4) Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in
丂dimethylnitrosamine treated rats.
丂Sun C, Teng Y, Li G, Yoshioka S, Yokota J, Miyamura M, Fang H, Zhang Y.
丂J Pharm Biomed Anal. 2010 ; 53: 98-102 (IF: 2.453)

婰帠

1) 彫栰愳夒塸丄媨懞廩旻
丂崅抦戝妛堛妛晹晬懏昦堾奜棃壔妛椕朄幒偺徯夘丏堛栻偺栧 2010; 50: 495-499

2) 孎扟捈巕丄斞嶳払梇丄杧揷愮塰丄媨懞廩旻丄幏報懢榊
丂儔儞僟儉壔斾妑帋尡偺榑暥傪撉傓偵偁偨偭偰乗榑暥偺僺僢僩儂乕儖乗 THE LUNG perspectives 2011; 19: 76-81丂

妛夛

媨懞廩旻
丂堛栻昳偺椪彴帋尡丄壚栘巣戝妛丒擔杮崅抦戝妛戞屲夞妛弍岎棳夛丄2010擭7寧10擔丄崟棿峕徣壚栘巣巗壚栘巣戝妛丄拞崙丂